Mylan appoints two members to board
This article was originally published in Scrip
Executive Summary
Global pharmaceutical company Mylan has appointed Melina Higgins and Rajiv Malik to its board of directors. Prior to joining Canonsburg, Pennsylvania-based Mylan, Ms Higgins served as a partner and in other senior roles at Goldman Sachs from 1989 until her retirement in January 2010. Mr Malik currently serves as president of Mylan and has held leadership positions at the firm since 2007. With the appointments of Ms Higgins and Mr Malik, Mylan expands its board to 13 members.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.